What makes an enterohemorrhagic Escherichia coli?

Clinical Infectious Diseases

Volumn 43, Issue 9, 2006, Pages 1168-1169

  Orth, Dorothea ^a   Würzner, Reinhard ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; CYTOLETHAL DISTENDING TOXIN; HEMOLYSIN; INTIMIN; METALLOPROTEINASE; PROTEINASE; SERINE PROTEINASE; SHIGA TOXIN; VEROTOXIN; VIRULENCE FACTOR; VEROTOXIN 1;

BACTERIAL GENE; BLOODY DIARRHEA; CYTOTOXICITY; EAE GENE; ENTEROHEMORRHAGIC ESCHERICHIA COLI; GENOTYPE; HEMOLYTIC ANEMIA; HEMOLYTIC UREMIC SYNDROME; KIDNEY FAILURE; MICROANGIOPATHY; NONHUMAN; NOTE; PRIORITY JOURNAL; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; STX GENE; THROMBOCYTOPENIA; TOXIN SYNTHESIS; CLASSIFICATION; ENTEROBACTER INFECTION; ESCHERICHIA COLI; HUMAN; METABOLISM; PATHOGENICITY;

ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; SHIGA-LIKE TOXIN I; VIRULENCE FACTORS;

EID: 33750118209     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/508207     Document Type: Note

References (10)

1. Tarr PI, Gordon CA, Chandler WL. Shiga toxin-producing Escherichia coli and the haemolytic uraemic syndrome. Lancet 2005; 365: 1073-86.
2. Mellmann A, Bielaszewska M, Zimmerhackl LB, et al. Enterohemorrhagic Escherichia coli in human infection: in vivo evolution of a bacterial pathogen. Clin Infect Dis 2005; 41: 785-92.
3. Noris M, Remuzzi G. Hemolytic uremic syndrome. J Am Soc Nephrol 2005; 16:1035-50.
4. Friedrich AW, Bielaszewska M, Zhang WL, et al. Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. J Infect Dis 2002; 185:74-84.
5. Pierard D, Muyldermans G, Moriau L, Stevens D, Lauwers S. Identification of new verocytotoxin type 2 variant B-subunit genes in human and animal Escherichia coli isolates. J Clin Microbiol 1998; 36:3317-22.
6. Sonntag AK, Bielaszewska M, Mellmann A, et al. Shiga toxin 2e-producing Escherichia coli isolates from humans and pigs differ in their virulence profiles and interactions with intestinal epithelial cells. Appl Environ Microbiol 2005; 71:8855-63.
7. Bielaszewska M, Friedrich AW, Aldick T, Schürk-Bulgrin R, Karch H. Shiga toxin activatable by intestinal mucus in Escherichia coli isolated from humans: predictor for a severe clinical outcome. Clin Infect Dis 2006; 43: 1160-7 (in this issue).
8. Orth D, Grif K, Dierich MP, Würzner R. Prevalence, structure and expression of urease genes in Shiga toxin-producing Escherichia coli from humans and the environment. Int J Hyg Environ Health (in press).
9. Karch H, Friedrich AW, Gerber A, Zimmerhackl LB, Schmidt MA, Bielaszewska M. New aspects in the pathogenesis of enteropathic hemolytic uremic syndrome. Semin Thromb Hemost 2006; 32:105-12.
10. Karch H, Tarr PI, Bielaszewska M. Enterohaemorrhagic Escherichia coli in human medicine. Int J Med Microbiol 2005; 295:405-18.